期刊文献+

辨证施治对拉米夫定治疗慢性乙肝增效作用及其对树突状细胞功能的影响 被引量:3

Effect of Synergy and Influence on Dendritic Cell Function that Determining the Treatment Based on Differentiation of Symptoms and Signs to Chronical Hepatitis B Treated by Lamivudine
原文传递
导出
摘要 目的:观察辨证施治对拉米夫定治疗慢性乙肝的增效作用及其对树突状细胞功能的影响。方法:收集120例慢性乙肝E-抗原阳性患者,分为观察组与对照组,观察组采用中医中药联合拉米夫定治疗,对照组仅用拉米夫定治疗,定期观察临床症状、肝功能、乙肝三系、HBV-DNA、YMDD变异等指标,疗程均为1年。疗程结束后两组各随机抽取30例病例,采集外周血检测树突状细胞表型及功能。结果:观察组与对照组相比,在改善临床症状、缩短肝功能、病毒载量恢复时间,提高E-抗原转换率、延长YMDD变异时间等方面经统计学处理有明显差异(P<0.05);观察组治疗后树突状细胞表型CD1 a、CD80、CD86、HLA-DR、ICAM-1明显高于对照组,经统计学处理有明显差异(P<0.05或P<0.01);刺激指数亦明显高于对照组(P<0.05)。结论:辨证施治能够提高拉米夫定治疗慢性乙肝的疗效,其机理与树突状细胞功能有关。 Objective: To observe the effect of synergy and the influence on dendritic cell function that determining the treatment based on differentiation of symptoms and signs to chronical hepatitis B treated by Lamivudine.Methods: 120 patients,with HBeAg positive were divided into two groups at random: observation group and control group,each group having sixty patients.Patients in the control group were only given to Lamivudine.Patients in the observation group were given to Lamivudine the usage same as control group and traditional Chinese medicine and drug.Observation item: Clinical symptoms、Liver function、HBV-DNA,HBeAg,YMDD.30 patients were selected each group that were detected dendritic cells phaenotype and function after treatment.Results: These of improving clinical symptoms,HBeAg divert,YMDD variation liver function and HBV-DNA's recovery were significantly different than those of control group.Dendritic cells phaenotype of observation group such as CD1a,CD80,CD86,HLA-DR,ICAM-1 were higher than those of control group(P〈0.05orP〈0.01);stimulation index and excreted factor IL-12 of observation group were higher than those of control group(P〈0.05).Conclusion: That determine the treatment based on differentiation of symptoms and signs can significantly improve the curative effect of chronical hepatitis B treated by Lamivudine and reduce the YMDD variation.one of the mechanism may be that it can improve dendritic cell function.
出处 《中华中医药学刊》 CAS 2008年第12期2752-2756,共5页 Chinese Archives of Traditional Chinese Medicine
关键词 辨证施治 拉米夫定 乙型肝炎 树突状细胞 Determine the treatment based on differentiation of symptoms and signs lamivudine hepatitis B virus dendritic cells
  • 相关文献

参考文献4

二级参考文献38

  • 1Zhang XX, Liu CM, Gong QM, et al. Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy. J Gastroenterolo Hepatolo, 2003, 1353-1357.
  • 2Schalm SW, Heathcote J, Cianciara J, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut, 2000, 46: 562-568.
  • 3Maria Buti, Rafael Esteban. Entecavir, FTC, L-RMAU, LdT and others. J Hepatol, 2003, 39: S139-S142.
  • 4Kirishima T, Okanoue T, Daimon Y, et al. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265
  • 5Liaw YF, Leung N, Guan R, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. J Gastroenterol Hepatol, 2003, 18: 239-245.
  • 6The EASL Jury. EASL international consensus conference on hepatitis B. J Hepatol, 2003, 38: 533-540.
  • 7Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology, 2001, 34: 1225-1241.
  • 8Li LL, Chun TW, Yin ML, et al. Prophylactic lamivudine prevents hepatitis B reactivation and mortality in patients receiving immunosuppression and chemotherapy. Hepatology, 2000, 32(Pt 2): 1183.
  • 9Liaw YF, Sung JJY, Chow WC, et al. Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prospective double-blined placebo-controlled clinical trial. Hepatology, 2003, 38(Suppl)1: 262A.
  • 10Fontana RJ. Mangement of patients with decompensated HBV cirrhosis. Seminars in liver disease. 2003 23: 89-100.

共引文献798

同被引文献46

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部